Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma
NCT07427992
·
clinicaltrials.gov ↗
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Sponsor
European Institute of Oncology